Drug Discovery and Clinical Development
MAS
Université de Genève (UNIGE)
- Lieu de formation
-
Genève (GE)
- Langue d'enseignement
-
anglais
- Type de formation
-
Hautes écoles universitaires HEU - Formation continue: formations longues
- Modalités temporelles
-
À temps partiel
- Thèmes de formation
-
Santé, soins, médecine
- Filières d'études
- Swissdoc
-
7.724.4.0
Mise à jour 07.07.2025
Description
Description de la formation
Le Master of Advanced Studies (MAS) est une formation postgrade donnée par les hautes écoles et elle équivaut à au moins 60 crédits ECTS. Le MAS in Drug Discovery and Clinical Development équivaut à 60 crédits ECTS.
Objectives
- Provide essential business knowledge of drug and medical devices in clinical research and development
- Give health professionals the tools to comply with the highest scientific and ethical standards in clinical research
- Empower physicians and health scientists to lead clinical trials within hospitals, pharmaceutical and biotechnology companies
- Enable health professionals to gain a strategic vision of clinical development and navigate the complexities of bringing new medicinal products to the global market
Plan de la formation
1 crédit ECTS correspond à environ 25-30 heures de travail.
Programme
13 modules:
- Introduction to Product Development: Challenges and Prospects
- Principles and Methods of Clinical Research
- Ethical and Regulatory Aspects
- Non-Clinical Development and Clinical Pharmacology
- Safety Management During Drug Development
- Medical Statistics and Trial Methodologies
- Clinical Trial Planning and Set-Up
- Clinical Trial Conduct and Close out
- Audits and Inspections
- Chemistry Manufacturing and Controls or
- Clinical Development of Anti-Cancer and Anti-Infective vaccines
- Regulatory Strategy in Product Development
- Medical Devices
- New Perspectives in Product Development
Thesis
Admission
Conditions d’admission
Admission criteria
- Medical degree (physician title), or
- Master’s or Bachelor’s degree in Life Sciences or an equivalent qualification, or
- Bachelor’s degree from a Swiss University of Applied Sciences plus at least one year of relevant professional experience
- Good command of English (level B2–C1)
Candidates attending the programme during working hours must provide written authorisation from their employer.
Audience
Medical doctor, biologist, pharmacist, veterinarians, nurse, biochemist and other professional involved or wishing to gain skills and knowledge in the field of drug discovery and development.
Coûts
Tuition Fee
- CHF 15'500.– for the whole MAS
For individual modules:
- 1-day module: CHF 1'000.-
- 2-day module: CHF 1'400.-
- 3-day module: CHF 1'800.-
- 4-day module: CHF 2'200.-
Diplôme
- Master of Advanced Studies MAS
MAS en découverte et développement clinique de médicaments / MAS in Drug Discovery and Clinical Development (60 ECTS credits), University of Geneva.
Infos pratiques
Lieu / adresse
- Genève (GE)
Format: On-site.
Déroulement temporel
Début des cours
August, every two years.
Durée de la formation
A minimum of 2 semesters and a maximum of 4 semesters.
Modalités temporelles
- À temps partiel
Langue d’enseignement
- anglais
Remarques
Accreditation The course programme is accredited by:
- Swissethics
- Swiss Association of Pharmaceutical Professionals (SwAPP)
- Swiss Society of Clinical Pharmacology and Toxicology (SGKPT-SSPTC)
- Swiss Institute for Postgraduate and Continuous Medical Education (SWIF-ISFM)
Related programme:
Liens
Renseignements / contact
Tel.: +41 (0)22 379 54 58
das-mas-clinical@unige.ch
Institution 1
Université de Genève (UNIGE)
Rue du Général-Dufour 24
1211 Genève 4
Tél.: +41 (0)22 379 71 11
URL:
www.unige.ch/
Autres informations
Centre pour la formation continue et à distance (CFCD)
Université de Genève (UNIGE)
Uni Pignon
Bd de Pont-d’Arve 42
1211 Genève 4
Tél.: +41 (0)22 379 78 33
E-mail:
URL:
www.unige.ch/formcont/